cefodizime has been researched along with imipenem, anhydrous in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Beuth, J; Grochla, I; Ko, HL; Pulverer, G; Roszkowski, K; Roszkowski, W | 1 |
3 other study(ies) available for cefodizime and imipenem, anhydrous
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Effects of beta-lactam antibiotics imipenem/cilastatin and cefodizime on cellular and humoral immune responses in BALB/c-mice.
Topics: Animals; Anti-Bacterial Agents; Antibody Formation; Cefotaxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Granulocytes; Hypersensitivity, Delayed; Imipenem; Immunity, Cellular; Male; Mice; Mice, Inbred BALB C; Monocytes; Opsonin Proteins; Phagocytosis | 1990 |